Filed: 2/7/2024ACC: 0001766721-24-000002
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $335.24M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$335.24M
Total AUM (reported)
22.39M
Total Shares
Allocation by class
COM$300.74M89.7%
SPONSORED ADS$30.61M9.1%
COM CL A$3.84M1.1%
CL A COM$51.2K0.0%
Portfolio Concentration
Top 3$289.29M86.3%
4–10$40.96M12.2%
11–25$4.99M1.5%
Top 3 weight
86.3%
Top 10 weight
98.5%
Voting Authority Distribution
Total shares with voting rights: 22.39M
Sole
Full voting authority
22.39M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$244.97M
73.07%
Sole
6.07M
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$22.17M
6.61%
Sole
1.12M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$22.15M
6.61%
Sole
1.02M
Shared
0.00
None
0.00
Biomea Fusion Inc (BMEA)
SOLEShares798.76K
TypeSH
Market value$11.60M
3.46%
Sole
798.76K
Shared
0.00
None
0.00
Compass Pathways Plc (CMPS)
SOLEShares964.50K
TypeSH
Market value$8.44M
2.52%
Sole
964.50K
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc (GLUE)
SOLEShares1.47M
TypeSH
Market value$8.32M
2.48%
Sole
1.47M
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$3.84M
1.14%
Sole
2.54M
Shared
0.00
None
0.00
Spruce Biosciences, Inc. (SPRB)
SOLEShares1.21M
TypeSH
Market value$3.53M
1.05%
Sole
1.21M
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$3.51M
1.05%
Sole
1.04M
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares314.29K
TypeSH
Market value$1.73M
0.52%
Sole
314.29K
Shared
0.00
None
0.00
Elevation Oncology Inc (ELEV)
SOLEShares2.83M
TypeSH
Market value$1.52M
0.45%
Sole
2.83M
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc (RPHM)
SOLEShares886.08K
TypeSH
Market value$1.42M
0.42%
Sole
886.08K
Shared
0.00
None
0.00
Avrobio, Inc. (AVRO)
SOLEShares1.01M
TypeSH
Market value$1.37M
0.41%
Sole
1.01M
Shared
0.00
None
0.00
Aclaris Theraputics Inc (ACRS)
SOLEShares434.45K
TypeSH
Market value$456.2K
0.14%
Sole
434.45K
Shared
0.00
None
0.00
Viracta Therapeutics Inc (VIRX)
SOLEShares288.57K
TypeSH
Market value$164.5K
0.05%
Sole
288.57K
Shared
0.00
None
0.00
Atreca Inc. (BCEL)
SOLEShares387.65K
TypeSH
Market value$51.2K
0.02%
Sole
387.65K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $244.97M 73.07% | 6.07M | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $22.17M 6.61% | 1.12M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $22.15M 6.61% | 1.02M | 0.00 | 0.00 |
Biomea Fusion Inc (BMEA)SOLE | COM | 798.76K | SH | $11.60M 3.46% | 798.76K | 0.00 | 0.00 |
Compass Pathways Plc (CMPS)SOLE | SPONSORED ADS | 964.50K | SH | $8.44M 2.52% | 964.50K | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc (GLUE)SOLE | COM | 1.47M | SH | $8.32M 2.48% | 1.47M | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $3.84M 1.14% | 2.54M | 0.00 | 0.00 |
Spruce Biosciences, Inc. (SPRB)SOLE | COM | 1.21M | SH | $3.53M 1.05% | 1.21M | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $3.51M 1.05% | 1.04M | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM | 314.29K | SH | $1.73M 0.52% | 314.29K | 0.00 | 0.00 |
Elevation Oncology Inc (ELEV)SOLE | COM | 2.83M | SH | $1.52M 0.45% | 2.83M | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc (RPHM)SOLE | COM | 886.08K | SH | $1.42M 0.42% | 886.08K | 0.00 | 0.00 |
Avrobio, Inc. (AVRO)SOLE | COM | 1.01M | SH | $1.37M 0.41% | 1.01M | 0.00 | 0.00 |
Aclaris Theraputics Inc (ACRS)SOLE | COM | 434.45K | SH | $456.2K 0.14% | 434.45K | 0.00 | 0.00 |
Viracta Therapeutics Inc (VIRX)SOLE | COM | 288.57K | SH | $164.5K 0.05% | 288.57K | 0.00 | 0.00 |
Atreca Inc. (BCEL)SOLE | CL A COM | 387.65K | SH | $51.2K 0.02% | 387.65K | 0.00 | 0.00 |